Zobrazeno 1 - 10
of 1 921
pro vyhledávání: '"Peritoneal metastases"'
Autor:
Peter Harald Cashin, MD, PhD, Dan Asplund, MD, PhD, Elinor Bexe Lindskog, MD, PhD, Lana Ghanipour, MD, PhD, Ingvar Syk, MD, PhD, Wilhelm Graf, MD, PhD, Per J. Nilsson, MD, PhD, Gabriella Jansson Palmer, MD, PhD
Publikováno v:
Surgery Open Science, Vol 20, Iss , Pp 45-50 (2024)
Background: Secondary treatment of recurrent colorectal peritoneal metastases after previous cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is poorly investigated. Objectives: To evaluate the overall survival outcom
Externí odkaz:
https://doaj.org/article/9e44d090412343c3aedf2f706f05d824
Autor:
Emi Ota, Yosuke Fukunaga, Toshiki Mukai, Yukiharu Hiyoshi, Tomohiro Yamaguchi, Toshiya Nagasaki, Takashi Akiyoshi
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Cytoreductive surgery and chemotherapy reportedly improve the prognosis of patients with metachronous peritoneal metastases. However, the types of peritoneal metastases indicated for cytoreductive surgery remains unclear. Therefor
Externí odkaz:
https://doaj.org/article/18293523ff3744a0a38d767a188a3f42
Publikováno v:
Oncology Reviews, Vol 18 (2024)
Peritoneal metastases (PM) are the spread of tumor forms into the peritoneum as metastases from another organ. PM is a frequent condition in metastatic gastrointestinal cancer (colorectal, gastric, pancreatic, appendiceal, and cholangiocarcinoma); th
Externí odkaz:
https://doaj.org/article/31ac7d4d6e8840f88c9c6d93c5ee0501
Autor:
V. Massa, F. Signorini, F. Salani, M.E. Filice, G. Grelli, P. Lippolis, P. Faviana, V. Genovesi, S. Santi, C. Vivaldi, S. Cesario, A. Bertolucci, C. Cremolini, V. Nardini, G. Masi, C. Ugolini, L. Fornaro
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 5, Iss , Pp 100089- (2024)
Background: Programmed death-ligand 1 (PD-L1) expression serves as a predictive biomarker for response to immune checkpoint inhibitors (ICIs) in metastatic gastroesophageal adenocarcinoma (mGEA). The peritoneum is one of the most common metastatic si
Externí odkaz:
https://doaj.org/article/363c31ba4cd042449b7e5199c56f6c1e
Autor:
Kurinchi Gurusamy, Jeffrey Leung, Claire Vale, Danielle Roberts, Audrey Linden, Xiao Wei Tan, Priyal Taribagil, Sonam Patel, Elena Pizzo, Brian Davidson, Tim Mould, Mark Saunders, Omer Aziz, Sarah O’Dwyer
Publikováno v:
Health Technology Assessment, Vol 28, Iss 51 (2024)
Background We compared the relative benefits, harms and cost-effectiveness of hyperthermic intraoperative peritoneal chemotherapy + cytoreductive surgery ± systemic chemotherapy versus cytoreductive surgery ± systemic chemotherapy or systemic chemo
Externí odkaz:
https://doaj.org/article/e707390caf0d4f1fb0d7b977f2f3116d
Autor:
Luca Varinelli, Davide Battistessa, Marcello Guaglio, Susanna Zanutto, Oscar Illescas, Ewelina J. Lorenc, Federica Pisati, Shigeki Kusamura, Laura Cattaneo, Giovanna Sabella, Massimo Milione, Alessia Perbellini, Sara Noci, Cinzia Paolino, Elisabetta Kuhn, Margherita Galassi, Tommaso Cavalleri, Marcello Deraco, Manuela Gariboldi, Dario Baratti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-20 (2024)
Abstract Background Peritoneal metastases from colorectal cancer (CRCPM) are related to poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been reported to improve survival, but peritoneal recurrenc
Externí odkaz:
https://doaj.org/article/df7a05ea572a4b8e81443d792ffa18d5
Autor:
Maria Alessandra Bellia, Carmelo Sofia, Maria Adele Marino, Carmelo Mazzeo, Santino Antonio Biondo, Eugenio Cucinotta, Francesco Fleres
Publikováno v:
Radiology Case Reports, Vol 19, Iss 5, Pp 2013-2019 (2024)
Regorafenib is a multikinase inhibitor approved for treatment of patients with metastatic Colo-Rectal Cancer (mCRC) and Gastro-Intestinal Stromal Tumor (GIST) progression after the administration of other tyrosine-kinase inhibitors such as imatinib a
Externí odkaz:
https://doaj.org/article/02ddf9ff59f34433bffcff176e7f60ab
Autor:
Mina Sarofim, Ruwanthi Wijayawardana, Nima Ahmadi, Shoma Barat, Winston Liauw, David L Morris
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-7 (2024)
Abstract Background Colorectal peritoneal metastases (CRPM) affects 15% of patients at initial colorectal cancer diagnosis. Neoadjuvant chemotherapy (NAC) prior to cytoreductive surgery (CRS) has been demonstrated to be a safe and feasible option, ho
Externí odkaz:
https://doaj.org/article/337d8129953946d6b9400432b954cf21
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background Colorectal peritoneal metastases (CRPM) are present in 10–20% of patients at the time of their initial cancer diagnosis, and affects over 20% of those who develop colorectal cancer recurrence. Cytoreductive surgery (CRS) with HI
Externí odkaz:
https://doaj.org/article/9be057fb6d2c4524b6ec35896406a5d8
Publikováno v:
International Journal of Hyperthermia, Vol 41, Iss 1 (2024)
Background The greater omentum is routinely resected during cytoreductive surgery (CRS), but few studies have analyzed the rationale behind this. This study aimed to assess the prevalence of omental metastases (OM) and the correlation between macrosc
Externí odkaz:
https://doaj.org/article/44b7874301ea4957bae7601c56cd2e62